Menu
C

Centre Hospitalier Universitaire de Lille | Claude Huriez Hospital - Gastroenterology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Vorasidenib
Zevalin
ANV419
Pegcetacoplan
Soliris
Indocyanine Green
NX210c
Tiuxetan
FOLFOX

Parent organization

This site is a part of Centre Hospitalier Universitaire de Lille

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

This study will investigate the efficacy, safety, tolerability and pharmacokinetics (PK) of multiple intravenous infusions of NX210c, at two dose lev...

Enrolling
Amyotrophic Lateral Sclerosis
Drug: NX210c
Drug: Placebo

Decathlon has developed ankleSOFT100 product which is medical device designed to reduce pain and joint instability during sport practice. The objecti...

Enrolling
Chronic Pain
Chronic Instability of Ankle Joint
Device: ankleSOFT100

Decathlon has developed kneeSOFT500 product, which is a medical device intended to be used on the knee to keep a physical activity on a regular basis...

Enrolling
Patellofemoral Pain Syndrome
Patellar Instability
Device: kneeSOFT500

Decathlon has developed the Elbow soft300 which is a medical device that must be positioned around the elbow to keep a physical activity on a regular...

Enrolling
Epicondylitis
Tendonitis Elbow
Other: Control group
Device: Elbow SOFT 300

Phase 3, multicenter, international, open-label, randomized, 2-arm trial investigating the safety and efficacy of IO102-IO103 in combination with pem...

Active, not recruiting
Unresectable Melanoma
Metastatic Melanoma
Drug: Pembrolizumab
Drug: IO102-IO103

This clinical study will test a newly developed cochlear implant known as CI622D. This experimental cochlear implant has been designed to slowly rele...

Active, not recruiting
Hearing Loss, Bilateral Sensorineural
Hearing Loss, Bilateral
Device: CI622
Device: CI622D

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture...

Enrolling
Open Midline Laparotomy
Device: Phasix™ Mesh

The study objective is to compare water vapor thermotherapy with the REZŪM™ System to dual drug therapy for the treatment of symptomatic benign prost...

Active, not recruiting
Benign Prostatic Hyperplasia (BPH)
Drug: alpha blocker and 5-alpha reductase inhibitor
Device: REZŪM

This study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Datopotamab Deruxtecan
Drug: Pembrolizumab

The purpose of RECOVER is to evaluate the performance and safety of Transorb™ self-gripping resorbable mesh in high-risk subjects (at least one risk...

Enrolling
Hernia Abdominal Wall
Hernia, Abdominal
Device: Transorb™ Self-Gripping Resorbable Mesh
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trial sponsors

D
C
C
G
A
A
A
B
Boston Scientific logo
C